Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Merck's Keytruda therapy with chemotherapy failed Phase 3 trial for high-risk endometrial cancer disease-free survival.

flag Merck's Keytruda therapy in combination with chemotherapy failed to meet the main goal of disease-free survival in high-risk endometrial cancer patients after surgery in a Phase 3 trial. flag The study's other main goal of overall survival was not formally tested due to the trial's failure. flag Endometrial cancer begins in the uterus's inner lining and is the most common form affecting the organ.

5 Articles

Further Reading